Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus
Completed
University of Alabama at Birmingham
N/A
2000-06-01
OBJECTIVES: I. Determine the effect of oral contraceptives containing low-dose synthetic
estrogens and progestins on disease activity in premenopausal women with inactive, stable, or
moderate systemic lupus erythematosus (SLE).
II. Determine the effect of hormone replacement therapy with conjugated estrogens and
progestins on disease activity in postmenopausal women with inactive, stable, or moderate
SLE.
Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus
Completed
National Center for Research Resources (NCRR)
N/A
2000-06-01
OBJECTIVES: I. Determine the effect of oral contraceptives containing low-dose synthetic
estrogens and progestins on disease activity in premenopausal women with inactive, stable, or
moderate systemic lupus erythematosus (SLE).
II. Determine the effect of hormone replacement therapy with conjugated estrogens and
progestins on disease activity in postmenopausal women with inactive, stable, or moderate
SLE.
A Clinical Trial to Evaluate the Safety and Efficacy of Enjuvia 0.3 mg for the Treatment of Vulvovaginal Atrophy
Completed
Duramed Research
Phase 3
2004-11-01
This is a two-arm, randomized, double-blind, parallel-group, placebo-controlled study to
evaluate the efficacy of Enjuvia 0.3 mg tablets for the treatment of moderate to severe
symptoms of vulvovaginal atrophy in postmenopausal women with or without a hysterectomy
and/or oophorectomy.
A Clinical Trial to Demonstrate the Efficacy and Safety of Cenestin 0.3 mg for the Treatment of Hot Flashes
Completed
Duramed Research
Phase 3
2005-12-01
This is a randomized, double-blind study to compare the efficacy and safety of daily doses of
Cenestin 0.3 mg tablets to placebo in reducing the frequency and severity of moderate to
severe hot flashes in postmenopausal women.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
